Market news

Detailed price information for Jack Henry & Assoc (JKHY-Q) from The Globe and Mail including charting and trades.

When examining a long-term compounder, astute market participants look past quarterly headlines to evaluate core operational drivers, margin stability, and pricing power. Addus HomeCare (NASDAQ:ADUS) embodies many classic characteristics of a durable portfolio holding: a sticky, non-franchise personal care delivery model, consistent organic growth, and a disciplined approach to capital allocation across fragmented regional markets. […]

Addus HomeCare (ADUS) heads into its 2026 Jefferies Healthcare Services and Technology Conference appearance with fresh attention on its AccentCare personal care acquisition and the stock’s recent sector driven move. After a strong run that produced a 23.45% 90 day share price return and lifted year to date share price gains to 8.73%, Addus HomeCare has seen momentum cool slightly in the last week as investors weigh the AccentCare deal, evolving Medicaid headlines, and the stock’s longer term...

Addus HomeCare (ADUS) has an average rating of overweight and mean price target of $133.69, accordin

Addus HomeCare' (ADUS) $275 million acquisition of AccentCare's personal care division will likely s

Addus HomeCare (ADUS) said Monday that it has agreed to acquire AccentCare's personal care division

Addus HomeCare's (ADUS) exposure to Medicaid funding pressures is expected to be offset by potential

FRISCO, Texas, September 14, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced a definitive agreement to acquire the personal care division of AccentCare for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million. The transaction relates only to AccentCare’s personal care operations outside of New York and does not relate to its hospice and home health operations. The acquired operations serve an

(Updated to include prior price target in headline.) Addus HomeCare (ADUS) has an average rating

Detailed price information for Western Digital Corp (WDC-Q) from The Globe and Mail including charting and trades.

FRISCO, Texas, September 08, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and Brad Bickham, Chief Operating Officer on an Interim Basis, will participate in the 2026 Jefferies Healthcare Services and Technology Conference, September 14 - 15, 2026, in Nashville, Tennessee.

Detailed price information for Ellington Financial Llc (EFC-N) from The Globe and Mail including charting and trades.

Addus HomeCare Q2 results and what they mean for the stock Addus HomeCare (ADUS) drew attention after reporting Q2 2026 results that showed revenue in line with expectations alongside an earnings per share beat. For investors, that mix raises fresh questions about how the stock reflects its fundamentals. The share price of Addus HomeCare has eased slightly in the short term, with the 1-day, 7-day and 30-day share price returns all down modestly, even after a strong 90-day share price return...

Addus HomeCare stock has delivered a 34.6% gain over the past three years, while a fresh intrinsic value estimate suggests the current price may still sit below what its future cash flows imply. The market price near US$118 puts investors between a strong historical return and an analytical view that points to possible undervaluation. A 34.6% share price gain over three years shows that Addus HomeCare has already rewarded patient investors, so the question is how much of the long term...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQ:ADUS) and its peers.

Investors need to pay close attention to ADUS stock based on the movements in the options market lately.

Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Addus HomeCare (ADUS) said Chief Operating Officer and President Heather Dixon is no longer with the

FRISCO, Texas, August 10, 2026--Addus HomeCare Corporation (Nasdaq: ADUS) (the "Company"), a provider of home care services, announced today that Heather Dixon, President and Chief Operating Officer, is no longer with the Company. Brad Bickham, former President and Chief Operating Officer at Addus, has agreed to return as Chief Operating Officer on an interim basis, effective immediately, for a period of one year.

Addus HomeCare (ADUS) reported impressive Q2 organic growth across its core personal care and hospic

Addus HomeCare (ADUS) has an average rating of overweight and mean price target of $134.85, accordin

Detailed price information for Addus Homecare Corp (ADUS-Q) from The Globe and Mail including charting and trades.

Addus HomeCare Corp (ADUS) reports 8% revenue growth and 16.1% adjusted EPS increase, while navigating hospice Medicare cap accruals and home health segment challenges.

Addus HomeCare (NASDAQ:ADUS) reported second-quarter 2026 revenue growth of 8% and adjusted earnings-per-share growth of 16.1%, supported by expansion in personal care and hospice services, improved cash generation and ongoing acquisition activity. Total net service revenues rose to $377.4 million

Addus HomeCare Corporation has now reported its second-quarter and first-half 2026 results, with Q2 net income of US$27.61 million and diluted EPS from continuing operations of US$1.49, both higher than the same periods in 2025. Alongside this, the company’s non-GAAP earnings per share modestly outpaced analyst expectations while maintaining an 11.5% adjusted operating margin, underscoring consistent profitability on essentially flat margins year over year. We’ll now examine how this...

Addus HomeCare (ADUS) attracted fresh attention after its Q2 2026 results, which matched Wall Street revenue expectations. Non-GAAP earnings per share and operating margins came in slightly ahead and remained steady year on year. See our latest analysis for Addus HomeCare. At a share price of $116.79, Addus HomeCare has seen a 30-day share price return of 11.05% and a 90-day share price return of 20.85%. The 1-year total shareholder return of 0.19% suggests recent momentum is building off a...

The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Addus HomeCare (ADUS) delivered earnings and revenue surprises of +2.37% and +0.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8% year on year to $377.4 million. Its non-GAAP profit of $1.73 per share was 1.9% above analysts’ consensus estimates.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Addus HomeCare (ADUS) reported Q2 adjusted earnings late Monday of $1.73 per diluted share, up from

FRISCO, Texas, August 03, 2026--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June 30, 2026.

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday after market hours. Here’s what you need to know.

FRISCO, Texas, July 20, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2026, on Monday, August 3, 2026, after the market close.

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how senior health, home health & hospice stocks fared in Q1, starting with Addus HomeCare (NASDAQ:ADUS).

Detailed price information for Addus Homecare Corp (ADUS-Q) from The Globe and Mail including charting and trades.